Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Mar 1;90(5):1790–1794. doi: 10.1073/pnas.90.5.1790

Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis.

E E Medrano 1, J Z Farooqui 1, R E Boissy 1, Y L Boissy 1, B Akadiri 1, J J Nordlund 1
PMCID: PMC45965  PMID: 8383327

Abstract

In the human epidermis, melanocytes are distributed at a distance from each other. In contrast, melanocytes in nevi, which are considered benign neoplasms of melanocytes, are grouped in nests. Although still not well defined, environmental factors are thought to play an important role in the development of nevi. We found that chronic growth stimulation by leukotriene C4, a compound found in increased amounts in inflamed skin, induced pleiotropic modifications in the normal melanocyte phenotype. These changes include loss of contact inhibition and formation of structures resembling tumor spheroids. In parallel with these changes, there was a constitutive expression of Fos protein. Switching these cultures to medium supplemented with phorbol ester sustained growth with reversion of the altered phenotype. In contrast, a cAMP stimulator, cholera toxin, induced features of terminal differentiation. Our findings suggest a role for inflammatory mediators in human epidermal melanocytes. This observation provides insight into melanocyte growth alterations which may have relevance in early stages of melanocyte oncogenesis.

Full text

PDF
1790

Images in this article

1791Fig. 1
on p.1791
1792Fig. 2
on p.1792
1793Fig. 3
on p.1793
1793Fig. 4
on p.1793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Malek Z. A., Swope V. B., Trinkle L. S., Nordlund J. J. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle. Exp Cell Res. 1989 Jan;180(1):198–208. doi: 10.1016/0014-4827(89)90224-3. [DOI] [PubMed] [Google Scholar]
  2. Abdel-Malek Z., Swope V. B., Pallas J., Krug K., Nordlund J. J. Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol. 1992 Feb;150(2):416–425. doi: 10.1002/jcp.1041500226. [DOI] [PubMed] [Google Scholar]
  3. Boissy R. E., Liu Y. Y., Medrano E. E., Nordlund J. J. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol. 1991 Sep;97(3):395–404. doi: 10.1111/1523-1747.ep12480976. [DOI] [PubMed] [Google Scholar]
  4. Clark W. H., Jr Human cutaneous malignant melanoma as a model for cancer. Cancer Metastasis Rev. 1991 Jun;10(2):83–88. doi: 10.1007/BF00049406. [DOI] [PubMed] [Google Scholar]
  5. Cramer S. F. The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med. 1991 Feb;115(2):115–119. [PubMed] [Google Scholar]
  6. Eisinger M., Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2018–2022. doi: 10.1073/pnas.79.6.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elder D. E. Human melanocytic neoplasms and their etiologic relationship with sunlight. J Invest Dermatol. 1989 May;92(5 Suppl):297S–303S. doi: 10.1111/1523-1747.ep13076732. [DOI] [PubMed] [Google Scholar]
  8. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  9. Fuller B. B., Viskochil D. H. The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. Life Sci. 1979 Jun 25;24(26):2405–2415. doi: 10.1016/0024-3205(79)90448-x. [DOI] [PubMed] [Google Scholar]
  10. Gallagher R. P., McLean D. I., Yang C. P., Coldman A. J., Silver H. K., Spinelli J. J., Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol. 1990 Jun;126(6):770–776. [PubMed] [Google Scholar]
  11. Gilchrest B. A., Treloar V., Grassi A. M., Yaar M., Szabo G., Flynn E. Characteristics of cultivated adult human nevocellular nevus cells. J Invest Dermatol. 1986 Jul;87(1):102–107. doi: 10.1111/1523-1747.ep12523599. [DOI] [PubMed] [Google Scholar]
  12. Gilchrest B. A., Vrabel M. A., Flynn E., Szabo G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol. 1984 Nov;83(5):370–376. doi: 10.1111/1523-1747.ep12264638. [DOI] [PubMed] [Google Scholar]
  13. Gordon P. R., Mansur C. P., Gilchrest B. A. Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol. 1989 Apr;92(4):565–572. doi: 10.1111/1523-1747.ep12709595. [DOI] [PubMed] [Google Scholar]
  14. Halaban R., Ghosh S., Duray P., Kirkwood J. M., Lerner A. B. Human melanocytes cultured from nevi and melanomas. J Invest Dermatol. 1986 Jul;87(1):95–101. doi: 10.1111/1523-1747.ep12523594. [DOI] [PubMed] [Google Scholar]
  15. Herlyn M., Clark W. H., Rodeck U., Mancianti M. L., Jambrosic J., Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest. 1987 May;56(5):461–474. [PubMed] [Google Scholar]
  16. Holly E. A., Kelly J. W., Shpall S. N., Chiu S. H. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987 Sep;17(3):459–468. doi: 10.1016/s0190-9622(87)70230-8. [DOI] [PubMed] [Google Scholar]
  17. Jonat C., Rahmsdorf H. J., Park K. K., Cato A. C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990 Sep 21;62(6):1189–1204. doi: 10.1016/0092-8674(90)90395-u. [DOI] [PubMed] [Google Scholar]
  18. Kwittken J. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review. J Med. 1991;22(1):1–16. [PubMed] [Google Scholar]
  19. Medrano E. E., Nordlund J. J. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol. 1990 Oct;95(4):441–445. [PubMed] [Google Scholar]
  20. Miller A. D., Curran T., Verma I. M. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell. 1984 Jan;36(1):51–60. doi: 10.1016/0092-8674(84)90073-4. [DOI] [PubMed] [Google Scholar]
  21. Morelli J. G., Yohn J. J., Lyons M. B., Murphy R. C., Norris D. A. Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol. 1989 Dec;93(6):719–722. doi: 10.1111/1523-1747.ep12284392. [DOI] [PubMed] [Google Scholar]
  22. Pathak M. A. Activation of the melanocyte system by ultraviolet radiation and cell transformation. Ann N Y Acad Sci. 1985;453:328–339. doi: 10.1111/j.1749-6632.1985.tb11821.x. [DOI] [PubMed] [Google Scholar]
  23. Pomerantz S. H. L-tyrosine-3,5-3H assay for tyrosinase development in skin of newborn hamsters. Science. 1969 May 16;164(3881):838–839. doi: 10.1126/science.164.3881.838. [DOI] [PubMed] [Google Scholar]
  24. Rhodes A. R., Harrist T. J., Day C. L., Mihm M. C., Jr, Fitzpatrick T. B., Sober A. J. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol. 1983 Oct;9(4):563–574. doi: 10.1016/s0190-9622(83)70171-4. [DOI] [PubMed] [Google Scholar]
  25. Rosdahl I., Rorsman H. An estimate of the melanocyte mass in humans. J Invest Dermatol. 1983 Sep;81(3):278–281. doi: 10.1111/1523-1747.ep12518318. [DOI] [PubMed] [Google Scholar]
  26. Sagebiel R. W. The dysplastic melanocytic nevus. J Am Acad Dermatol. 1989 Mar;20(3):496–501. doi: 10.1016/s0190-9622(89)80086-6. [DOI] [PubMed] [Google Scholar]
  27. Sassone-Corsi P., Visvader J., Ferland L., Mellon P. L., Verma I. M. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 1988 Dec;2(12A):1529–1538. doi: 10.1101/gad.2.12a.1529. [DOI] [PubMed] [Google Scholar]
  28. Sorahan T., Ball P. M., Grimley R. P., Pope D. Benign pigmented nevi in children from Kidderminster, England: prevalence and associated factors. J Am Acad Dermatol. 1990 May;22(5 Pt 1):747–750. doi: 10.1016/0190-9622(90)70102-n. [DOI] [PubMed] [Google Scholar]
  29. Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
  30. Voorhees J. J. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol. 1983 Jul;119(7):541–547. [PubMed] [Google Scholar]
  31. Yaar M., Woodley D. T., Gilchrest B. A. Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest. 1988 Feb;58(2):157–162. [PubMed] [Google Scholar]
  32. Yamanishi D. T., Buckmeier J. A., Meyskens F. L., Jr Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J Invest Dermatol. 1991 Aug;97(2):349–353. doi: 10.1111/1523-1747.ep12480698. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES